Moderna +177%, Merck +13% on Melanoma Vaccine Phase 3 Win
Moderna soared 177% and Merck jumped 13% on Aug 19 after intismeran plus Keytruda hit its primary endpoint in the Phase 3 INTerpath-001 melanoma trial.
Moderna soared 177% and Merck jumped 13% on Aug 19 after intismeran plus Keytruda hit its primary endpoint in the Phase 3 INTerpath-001 melanoma trial.
VWAP is the intraday benchmark institutions and traders share. Learn the formula, how to read it, and where it misleads.
Nebius announced a $4.5 billion two-tranche convertible senior notes offering to fund AI data center buildout after Q2 revenue jumped 454% to $582M.
Alphabet priced a four-tranche A$5.5B kangaroo on Aug 19 with orders above A$18B — more than 2x Apple’s prior AUD tech record, all to fund AI capex.
The chip selloff widened Monday as the AI supply chain got hit harder than the mega-cap designers. CoreWeave -12%, Lumentum -10%, SanDisk -9%, Seagate -9%.
Long-dated sovereign yields hit multi-year highs across the US, UK, Germany, and Japan in mid-August 2026 as buyers demand more term premium.
Semiconductors led a tech rout Aug 18 as the 10-year yield sat near 4.72%. Micron -7%, AMD -4.3%, SOX -4.98% — while Apple and Microsoft actually rose.
Databricks raised $5B at a $190B valuation on Aug 13, 2026 — Coatue led, with Blackstone, MGX, T. Rowe Price and new investor Sixth Street Growth in the syndicate.
HeartFlow’s Q2 2026 revenue rose 48% to $64.1M, non-GAAP gross margin hit 83.3%, and the AI cardiology company raised its FY26 guide to $246-$250M.
A gamma squeeze forces dealers hedging calls to buy stock, pushing it higher. Here’s the mechanism, how to spot one, and why GameStop wasn’t one.